Tocilizumab in Severe COVID-19 Disease: Does Timing Matters?

被引：0
|
作者：
Cherrez-Ojeda, I. [1 ]
Vanegas, E. [2 ]
Felix, M. [2 ]
Tovar, M. [3 ]
Bravo, P. [3 ]
Pena, J. [3 ]
Jauregui, J. [3 ]
Silva, D. [3 ]
Bolona, E. [3 ]
机构：
[1] Respiralab, Guayaquil, Ecuador
[2] Univ Espiritu Santo, Samborondon, Ecuador
[3] Clin Guayaquil, Guayaquil, Ecuador
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2653
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Tocilizumab in severe COVID-19
    Liberato, Nicola Lucia
    De Monte, Andrea
    Caravella, Giuseppe
    ARCHIVES OF MEDICAL SCIENCE, 2020, 16 (06) : 1457 - 1458
  • [2] Timing of Tocilizumab Use and COVID-19
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    RESPIRATORY CARE, 2022, 67 (03) : 381 - 381
  • [3] Tocilizumab for severe COVID-19 pneumonia
    Mourad, Jean-Jacques
    Azria, Philippe
    LANCET RHEUMATOLOGY, 2020, 2 (11): : E659 - E659
  • [4] Tocilizumab and COVID-19: Timing of Administration and Efficacy
    Abidi, Emna
    El Nekidy, Wasim S.
    Alefishat, Eman
    Rahman, Nadeem
    Petroianu, Georg A.
    El-Lababidi, Rania
    Mallat, Jihad
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [5] Tocilizumab and COVID-19: Timing of administration assessment
    Richier, Q.
    Jachiet, V
    Bonnemains, V
    Placais, L.
    Abisror, N.
    Garnier, M.
    Pacanowski, J.
    Dhote, R.
    Hinchschberger, O.
    Michel, M.
    Bienvenu, B.
    Comarmond, C.
    Lacombe, K.
    Mekinian, A.
    INFECTIOUS DISEASES NOW, 2022, 52 (01): : 31 - 34
  • [6] Repurposed Tocilizumab in Patients with Severe COVID-19
    Tian, Jianbo
    Zhang, Ming
    Jin, Meng
    Zhang, Fengqin
    Chu, Qian
    Wang, Xiaoyang
    Chen, Can
    Yue, Huihui
    Zhang, Li
    Du, Ronghui
    Zhao, Dong
    Zeng, Zhaofu
    Zhao, Yang
    Liu, Kui
    Wang, Mengmei
    Hu, Ke
    Miao, Xiaoping
    Zhang, Huilan
    JOURNAL OF IMMUNOLOGY, 2021, 206 (03): : 599 - 606
  • [7] Tocilizumab in severe COVID-19: A promise fulfilled
    Levi, Marcel
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 95 : 38 - 39
  • [8] Tocilizumab is recommended for the treatment of severe COVID-19
    Zhou, Yonggang
    Wei, Haiming
    EBIOMEDICINE, 2020, 61
  • [9] Tocilizumab, Adipokines and Severe Complications of COVID-19
    Fioravanti, Antonella
    Porcelli, Brunetta
    Terzuoli, Lucia
    Bacarelli, Maria Romana
    Tenti, Sara
    Cheleschi, Sara
    CLINICAL DRUG INVESTIGATION, 2020, 40 (09) : 891 - 892
  • [10] Tocilizumab, Adipokines and Severe Complications of COVID-19
    Antonella Fioravanti
    Brunetta Porcelli
    Lucia Terzuoli
    Maria Romana Bacarelli
    Sara Tenti
    Sara Cheleschi
    Clinical Drug Investigation, 2020, 40 : 891 - 892
12345